MIA Co-Medical Director opens SMR Congress in USA
21 November 2019
Professor Georgina Long, Co-Medical Director of Melanoma Institute Australia, has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
Professor Long is the first Australian and the first female President of SMR.
In her opening address, she summed up recent breakthroughs and advances in melanoma research and welcomed delegates from around the globe. This year's SMR Congress will cover a range of melanoma research and treatment related areas including the melanoma microenvironment, advances in early detection and prevention of melanoma, targeted and immunotherapies and advances in acral, mucosal and uveal melanoma. Women in STEM will also be a focus for the Congress.
Professor Long's opening address was followed by a Keynote Presentation on Cellular conversations that control cancer by University of California researcher, Professor Thea Tlsty, and the formal Welcome Reception. SMR continues into the weekend, with a packed program including a number of poster presentations from Melanoma Institute Australia researchers and students.
In sessions prior to the official opening, Co-Medical Director Professor Richard Scolyer led discussions at an International Melanoma Pathology Study Group workshop and the day-long International Melanoma Pathology Symposium.
The opening of SMR comes just a day after Professor Long and Professor Richard Scolyer were recognised as among the world’s most influential in their respective fields by being named in the prestigious Clarivate Analytics 2019 Highly Cited Researchers List.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.
They are a formidable team - in work and in play
This week, Melanoma Institute Australia hosted the first of six
Federal government urged
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Lauren O'Brien tells us why she's running for a cause close to her heart
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.